Inventor · disambiguated record
Kai Thede
Also filed as: THEDE KAI
31 granted patents·23 pending applications·79 citations·filing 2005–2023
95Inventor score
Top patents by PatentIndex Score
54 records- 0193US11492358B1Macrocyclic indole derivativesBAYER AG·Filed 2021·Granted Nov 8, 2022·3 cites·18 claims
- 0292US10981932B2Macrocyclic indole derivativesBAYER AG·Filed 2017·Granted Apr 20, 2021·9 cites·17 claims
- 0390US11891404B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2022·Granted Feb 6, 2024·1 cites·10 claims
- 0488US12152041B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2022·Granted Nov 26, 2024·1 cites·6 claims
- 0587US11440923B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2018·Granted Sep 13, 2022·3 cites·15 claims
- 0687US8389520B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesTHEDE KAI·Filed 2007·Granted Mar 5, 2013·8 cites·10 claims
- 0786US11478451B1Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Oct 25, 2022·3 cites·16 claims
- 0886US11401278B2Macrocyclic indole derivativesBROAD INST INC·Filed 2018·Granted Aug 2, 2022·3 cites·13 claims
- 0985US11447504B2Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Sep 20, 2022·3 cites·14 claims
- 1085US11286263B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2018·Granted Mar 29, 2022·3 cites·9 claims
- 1185US8653111B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesTHEDE KAI·Filed 2012·Granted Feb 18, 2014·7 cites·14 claims
- 1281US8524699B2Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitorsTHEDE KAI·Filed 2007·Granted Sep 3, 2013·6 cites·10 claims
- 1381US8252817B2Dipyridyl-dihydropyrazolones and their useFLAMME INGO·Filed 2006·Granted Aug 28, 2012·7 cites·10 claims
- 1479US7569563B2Substituted quinolones IIAICURIS GMBH & CO KG·Filed 2007·Granted Aug 4, 2009·4 cites·11 claims
- 1578US8609698B2Substituted dipyridyl-dihydropyrazolones and use thereofTHEDE KAI·Filed 2007·Granted Dec 17, 2013·4 cites·14 claims
- 1675US9278925B2Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-oneLIU NINGSHU·Filed 2012·Granted Mar 8, 2016·3 cites·8 claims
- 1773US9000026B2Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapyLIU NINGSHU·Filed 2012·Granted Apr 7, 2015·2 cites·7 claims
- 1872US9168249B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2015·Granted Oct 27, 2015·1 cites·2 claims
- 1972US8987261B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2013·Granted Mar 24, 2015·1 cites·7 claims
- 2071US8030347B2Cylopenta[b]benzofuran derivatives and the utilization thereofBAYER HEALTHCARE AG·Filed 2005·Granted Oct 4, 2011·2 cites·15 claims
- 2171US7977349B2Substituted quinolones IIIAICURIS GMBH & CO KG·Filed 2008·Granted Jul 12, 2011·1 cites·12 claims
- 2269US8399682B2Substituted (pyrazolylcarbonyl)imidazolidinones and their useTHEDE KAI·Filed 2010·Granted Mar 19, 2013·2 cites·26 claims
- 2367US9085572B24-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseasesFLAMME INGO·Filed 2012·Granted Jul 21, 2015·1 cites·6 claims
- 2464US8324268B2Substituted furancarboxamides, and use thereofTHEDE KAI·Filed 2011·Granted Dec 4, 2012·1 cites·16 claims
- 2561US2025066370A1Bicyclic triazine derivatives for the treatment of cancerDEUTSCHES KREBSFORSCH·Filed 2023·Application pending·0 cites
- 2661US2025346593A1Imidazo(1,2-1)pyridine derivatives as ripk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2757US2011201564A1Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2854US9212140B2(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatmentLIU NINGSHU·Filed 2012·Granted Dec 15, 2015·0 cites·2 claims
- 2954US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 3054US2023192700A1Pyrazolopyrazines acting on cancers via inhibition of cdk12BAYER AG·Filed 2021·Application pending·0 cites
- 3154US2016229858A1Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2015·Application pending·0 cites
- 3253US2023106032A1Imidazotriazines acting on cancer via inhibition of cdk12BAYER AG·Filed 2021·Application pending·0 cites
- 3353US2023212532A1P450 bm3 monooxygenase variants for c19-hydroxylation of steroidsBAYER AG·Filed 2021·Application pending·0 cites
- 3452US8063234B2Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereofKOLKHOF PETER·Filed 2009·Granted Nov 22, 2011·0 cites·26 claims
- 3551US2023117034A1PyrazolotriazinesBAYER AG·Filed 2020·Application pending·0 cites
- 3650US2011183928A13-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 3749US12338250B2Methods of preparing macrocyclic indolesBROAD INST INC·Filed 2020·Granted Jun 24, 2025·0 cites·20 claims
- 3848US2023013419A1Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamideBAYER AG·Filed 2020·Application pending·0 cites
- 3948US2010022527A1Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseasesAICURIS GMBH & CO KG·Filed 2009·Application pending·0 cites
- 4045US7867992B2Substituted quinolonesAICURIS GMBH & CO KG·Filed 2007·Granted Jan 11, 2011·0 cites·16 claims
- 4145US2010105673A1Substituted aminofuranones and their useBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 4243US2021253598A1Aryl annulated macrocyclic indole derivativesBAYER AG·Filed 2018·Application pending·0 cites
- 4342US10130633B2CompoundsBayer Pharma AG·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 4442US2016052898A1Novel compoundsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4539US2007099929A1Substituted thiophenesAICURIS GMBH & CO KG·Filed 2006·Application pending·0 cites
- 4638US8575357B2Substituted (thiazolyl-carbonyl)imidazolidinones and use thereofTHEDE KAI·Filed 2012·Granted Nov 5, 2013·0 cites·14 claims
- 4737US2013040935A1Cyclic keto-enols for therapyBAYER IP GMBH·Filed 2011·Application pending·0 cites
- 4836US8546438B2Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereofTHEDE KAI·Filed 2011·Granted Oct 1, 2013·0 cites·12 claims
- 4936US2012129833A1Cyclic ketoenols for therapyLIU NINGSHU·Filed 2011·Application pending·0 cites
- 5033US2018044306A11,3,4-thiadiazol-2-yl-benzamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kai Thede files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →